Immunization with ICs induces anti-tumor immunity in Irf8 Δ32 mice. (A) Tumor growth from Fig. 5 A. (B) CD4⁺ and CD8α⁺ T cells were evaluated in peripheral blood before (day −1) or 1 day after (day 0) i.p. administration of 100 μg anti-CD8β antibody. Lymphocytes were pregated as CD3⁺ CD11c⁻ cells. Data shown are representative flow plots from two independent experiments.